Trained immunity: Target for prophylaxis and therapy

A Ziogas, M Bruno, R van der Meel, WJM Mulder… - Cell Host & Microbe, 2023 - cell.com
Trained immunity is a de facto memory for innate immune responses, leading to long-term
functional reprogramming of innate immune cells. In physiological conditions, trained …

The role of trained immunity in COVID-19: Lessons for the next pandemic

MG Netea, A Ziogas, CS Benn… - Cell Host & Microbe, 2023 - cell.com
Trained immunity is a long-term increase in responsiveness of innate immune cells, induced
by certain infections and vaccines. During the last 3 years of the COVID-19 pandemic …

Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2

KL Hilligan, S Namasivayam, CS Clancy… - Nature …, 2023 - nature.com
Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication;
however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We …

Trained immunity: General and emerging concepts

P Vuscan, B Kischkel, LAB Joosten… - Immunological …, 2024 - Wiley Online Library
Over the past decade, compelling evidence has unveiled previously overlooked adaptive
characteristics of innate immune cells. Beyond their traditional role in providing short, non …

Interpreting the results of trials of BCG vaccination for protection against COVID-19

CCA Noble, NL Messina, LF Pittet… - The Journal of Infectious …, 2023 - academic.oup.com
BCG vaccination has beneficial off-target (“nonspecific”) effects on nonmycobacterial
infections. On this premise, trials set out to investigate whether BCG provides off-target …

BCG Vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial

J Claus, T Ten Doesschate, C Gumbs… - MBio, 2023 - Am Soc Microbiol
ABSTRACT Bacillus Calmette-Guerin (BCG) vaccination has been hypothesized to reduce
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, severity, and/or …

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis

P Booysen, KA Wilkinson, D Sheerin, R Waters… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) are major infectious causes of death,
with meta-analyses and population-based studies finding increased mortality in co-infected …

[HTML][HTML] Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled …

EL Koekenbier, K Fohse, JS van de Maat… - Clinical Microbiology …, 2023 - Elsevier
Abstract Objectives To test whether Bacillus Calmette-Guérin (BCG) vaccination would
reduce the incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults …

BCG mediated protection of the lung against experimental SARS-CoV-2 infection

KL Hilligan, S Namasivayam, A Sher - Frontiers in immunology, 2023 - frontiersin.org
The observation of reduced COVID-19 incidence and severity in populations receiving
neonatal intradermal BCG vaccination vaccine raised the question of whether BCG can …

Superinfection with SARS-CoV-2 has deleterious effects on Mycobacterium bovis BCG immunity and promotes dissemination of Mycobacterium tuberculosis

RE Hildebrand, SS Chandrasekar, M Riel… - Microbiology …, 2022 - Am Soc Microbiol
An estimated one-third of the world's population is infected with Mycobacterium tuberculosis,
with the majority being vaccinated with Mycobacterium bovis BCG. Severe acute respiratory …